Preferred Name |
Cefdinir |
|
Synonyms |
|
|
Definitions |
A semi-synthetic cephalosporin and a beta-lactam antibiotic with bactericidal activity. Cefdinir's effect is dependent on its binding to penicillin-binding proteins (PBPs) located in the bacterial cytoplasmic membrane. Binding results in the inhibition of the transpeptidase enzymes, thereby preventing cross-linking of the pentaglycine bridge with the fourth residue of the pentapeptide and interrupting consequent synthesis of peptidoglycan chains. As a result, cefdinir inhibits bacterial septum and cell wall synthesis formation. |
|
ID |
http://purl.obolibrary.org/obo/NCIT_C28914 |
|
CAS_Registry |
91832-40-5 |
|
CHEBI_ID |
CHEBI:3485 |
|
Chemical_Formula |
C14H13N5O5S2 |
|
code |
C28914 |
|
Contributing_Source |
FDA |
|
definition |
A semi-synthetic cephalosporin and a beta-lactam antibiotic with bactericidal activity. Cefdinir's effect is dependent on its binding to penicillin-binding proteins (PBPs) located in the bacterial cytoplasmic membrane. Binding results in the inhibition of the transpeptidase enzymes, thereby preventing cross-linking of the pentaglycine bridge with the fourth residue of the pentapeptide and interrupting consequent synthesis of peptidoglycan chains. As a result, cefdinir inhibits bacterial septum and cell wall synthesis formation. |
|
FDA_UNII_Code |
CI0FAO63WC |
|
in_subset | ||
label |
Cefdinir |
|
Legacy Concept Name |
Cefdinir |
|
Preferred_Name |
Cefdinir |
|
prefixIRI |
NCIT:C28914 |
|
prefLabel |
Cefdinir |
|
Semantic_Type |
Organic Chemical Pharmacologic Substance Antibiotic |
|
UMLS_CUI |
C0060405 |
|
subClassOf |